Exom Group

Cheers to a new year filled with success, innovation, and opportunities! Here’s wishing our esteemed clients, partners and colleagues a very happy and prosperous 2024. May this year bring you endless joy and numerous accomplishments. Looking forward to working with you in 2024.

Accelerating the future of clinical trials! Exom Group, in collaboration with AWS Partner Storm Reply, has automated remote patient consent with -powered chatbot technology. This digital revolution bypasses the need for in-person informed consent and boosts participation rates by allowing easy access through email and text.

Explore this life-saving innovation here: https://sqr.co/aws-vEngage/

Together, we are working towards a brighter future for those living with inherited arrhythmogenic cardiomyopathy (ACM). With the support of the European Union and leading experts in preclinical research and cardiac genetics, we are proud to be part of the Geremy project – a project seeking a genetic cure for ACM. Read more at https://swiy.co/EXG-GEREMY